Clinic
Bella Vida Health Care and Medi Spa
Bella Vida Health Care and Medi Spa was paid $7.18M by Medicaid between Jan 2018 and Dec 2024, across 50 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 45% of everything it billed.
33Billing provider infoBELLA VIDA HEALTH CARE AND MEDI SPA
LOS LUNAS, NM 87031
LOS LUNAS, NM 87031
33aNPI1568704237assigned 03/20/2013
33bProvider typeHealth Service Clinic/Center
28Total paid$7.18M
24GClaims127,554
24DCodes billed50
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Health Service Clinic/Center providers in New Mexico
Rank by total paid#1 of 17
Median peer was paid$243K
This provider vs. median29×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 23,290 | $919K | |
| 2019 | 18,356 | $1.00M | |
| 2020 | 12,315 | $769K | |
| 2021 | 16,044 | $935K | |
| 2022 | 19,869 | $1.07M | |
| 2023 | 20,461 | $1.25M | |
| 2024incomplete | 17,219 | $1.23M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 45% | 47,114 | 45,951 | $3.20M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 39% | 29,240 | 28,117 | $2.78M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 9.3% | 6,890 | 6,845 | $670K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.9% | 8,387 | 8,331 | $135K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.1% | 3,333 | 2,451 | $78K |
| 36415 | Collection of venous blood by venipuncture | <1% | 8,344 | 8,104 | $38K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 375 | 374 | $34K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 238 | 237 | $34K |
| 99173 | <1% | 768 | 765 | $29K | |
| 99051 | <1% | 892 | 864 | $29K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,601 | 1,480 | $28K |
| 81003 | <1% | 12,141 | 11,916 | $26K |
38 more codes
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 237 | $24K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 124 | $12K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,014 | $11K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 107 | $10K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 149 | $8K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 223 | $8K |
| 81025 | <1% | 788 | $7K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 39 | $4K |
| 87807 | <1% | 162 | $2K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 228 | $2K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 80 | $2K |
| 93000 | <1% | 115 | $1K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 13 | $1K |
| A7015 | Aerosol mask, used with dme nebulizer | <1% | 724 | $1K |
| 82947 | <1% | 299 | $1K | |
| 82043 | <1% | 192 | $982.54 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 21 | $784.02 |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 22 | $560.69 |
| 98968 | <1% | 13 | $368.74 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 87 | $178.95 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 366 | $164.91 |
| 96127 | <1% | 14 | $126.75 | |
| 85018 | <1% | 57 | $123.23 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 510 | $70.25 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 14 | $54.19 |
| 82962 | <1% | 12 | $31.76 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 86 | $3.62 |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 13 | $0.64 |
| 3210F | 0% | 138 | $0.00 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 296 | $0.00 |
| 3725F | 0% | 13 | $0.00 | |
| 3077F | 0% | 12 | $0.00 | |
| 4120F | 0% | 12 | $0.00 | |
| 4013F | 0% | 13 | $0.00 | |
| 3008F | 0% | 985 | $0.00 | |
| 1220F | 0% | 844 | $0.00 | |
| G8419 | Bmi documented outside normal parameters, no follow-up plan documented, no reason given | 0% | 125 | $0.00 |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 84 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCHAVEZ, FRANK (OPERATIONS)